Role of the Tau N-terminal region in microtubule stabilization revealed by new endogenous truncated forms

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Derisbourg, Maxime ^a,b,c   Leghay, Coline ^a,b,c   Chiappetta, Giovanni ^d   Fernandez Gomez, Francisco Jose ^a,b   Laurent, Cyril ^a,b   Demeyer, Dominique ^a,b,c   Carrier, Sébastien ^a,b,c   Buée Scherrer, Valérie ^a,b,c   Blum, David ^a,b,c   Vinh, Joëlle ^d   Sergeant, Nicolas ^a,b,c   Verdier, Yann ^d   Buée, Luc ^a,b,c   Hamdane, Malika ^a,b,c  

^a INSERM   (France)

^b UNIV LILLE   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d PSL RESEARCH UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MAPT PROTEIN, HUMAN; PROTEIN BINDING; TAU PROTEIN; TUBULIN;

ACETYLATION; ALZHEIMER DISEASE; BRAIN; CELL LINE; GENETICS; HUMAN; METABOLISM; MICROTUBULE; NERVE DEGENERATION; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; PROTEOMICS;

ACETYLATION; ALZHEIMER DISEASE; BRAIN; CELL LINE; HUMANS; MICROTUBULES; NERVE DEGENERATION; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOMICS; TAU PROTEINS; TUBULIN;

EID: 84929353239     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09659     Document Type: Article

References (56)

1. Andreadis, A., Brown, W. M. & Kosik, K. S. Structure and novel exons of the human tau gene. Biochemistry 31, 10626-10633 (1992).
2. Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D. & Crowther, R. A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3, 519-526 (1989).
3. Himmler, A., Drechsel, D., Kirschner, M. W. & Martin, D. W. Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains. Mol. Cell. Biol. 9, 1381-1388 (1989).
4. Drechsel, D. N., Hyman, A. A., Cobb, M. H. & Kirschner, M. W. Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. Mol. Biol. Cell 3, 1141-1154 (1992).
5. Stamer, K., Vogel, R., Thies, E., Mandelkow, E. & Mandelkow, E. M. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. The Journal of Cell Biology 156, 1051-1063 (2002).
6. Brandt, R., Léger, J. & Lee, G. Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J. Cell Biol. 131, 1327-1340 (1995).
7. Loomis, P. A., Howard, T. H., Castleberry, R. P. & Binder, L. I. Identification of nuclear tau isoforms in human neuroblastoma cells. Proc. Natl. Acad. Sci. U.S.A. 87, 8422-8426 (1990).
8. Lee, G., Newman, S. T., Gard, D. L., Band, H. & Panchamoorthy, G. Tau interacts with src-family non-receptor tyrosine kinases. J. Cell. Sci. 111 (Pt 21), 3167-3177 (1998).
9. Sergeant, N. et al. Biochemistry of Tau in Alzheimer's disease and related neurological disorders. Expert Rev Proteomics 5, 207-224 (2008).
10. Delacourte, A. et al. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 52, 1158-1165 (1999).
11. Braak, H., Thal, D. R., Ghebremedhin, E. & Del Tredici, K. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70, 960-969 (2011).
12. Alonso, A. C., Zaidi, T., Grundke-Iqbal, I. & Iqbal, K. Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 91, 5562-5566 (1994).
13. Fasulo, L. et al. The neuronal microtubule-associated protein tau is a substrate for caspase-3 and an effector of apoptosis. Journal of Neurochemistry 75, 624-633 (2000).
14. Matthews-Roberson, T. A., Quintanilla, R. A., Ding, H. & Johnson, G. V. W. Immortalized cortical neurons expressing caspase-cleaved tau are sensitized to endoplasmic reticulum stress induced cell death. Brain Res. 1234,206-212 (2008).
15. Amadoro, G. et al. NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation. Proc. Natl. Acad. Sci. U.S.A. 103, 2892-2897 (2006).
16. Zhang, Z. et al. Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease. Nat. Med. doi:10.1038/nm.3700 (2014).
17. Zilka, N. et al. Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo. FEBS Letters 580, 3582-3588 (2006).
18. de Calignon, A. et al. Caspase activation precedes and leads to tangles. Nature 464, 1201-1204 (2010).
19. Watanabe, A., Takio, K. & Ihara, Y. Deamidation and isoaspartate formation in smeared tau in paired helical filaments. Unusual properties of the microtubulebinding domain of tau. J Biol Chem 274, 7368-7378 (1999).
20. Zilka, N., Kovacech, B., Barath, P., Kontsekova, E. & Novak, M. The selfperpetuating tau truncation circle. Biochem Soc Trans 40, 681-686 (2012).
21. Novak, M., Kabat, J. & Wischik, C. M. Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. EMBO J 12, 365-370 (1993).
22. Gamblin, T. C. et al. Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 100, 10032-10037 (2003).
23. Rissman, R. A. et al. Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. Journal of Clinical Investigation 114, 121-130 (2004).
24. Guo, H. et al. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease. Am J Pathol 165, 523-531 (2004).
25. Horowitz, P. M. et al. Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease. J. Neurosci. 24, 7895-7902 (2004).
26. Basurto-Islas, G. et al. Accumulation of aspartic acid421- and glutamic acid391- cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease. J Neuropathol Exp Neurol 67, 470-483 (2008).
27. Porzig, R., Singer, D. & Hoffmann, R. Epitope mapping of mAbs AT8 and Tau5 directed against hyperphosphorylated regions of the human tau protein. Biochem Biophys Res Commun 358, 644-649 (2007).
28. Hasegawa, M. et al. Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain. J Biol Chem 267, 17047-17054 (1992).
29. Sarkar, M., Kuret, J. & Lee, G. Two motifs within the tau microtubule-binding domain mediate its association with the hsc70 molecular chaperone. J. Neurosci. Res. 86, 2763-2773 (2008).
30. Biernat, J., Gustke, N., Drewes, G., Mandelkow, E. M. & Mandelkow, E. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron 11, 153-163 (1993).
31. Xie, H., Litersky, J. M., Hartigan, J. A., Jope, R. S. & Johnson, G. V. The interrelationship between selective tau phosphorylation and microtubule association. Brain Res. 798, 173-183 (1998).
32. Al-Bassam, J. & Corbett, K. D. a-Tubulin acetylation from the inside out. Proc Natl Acad Sci USA 109, 19515-19516 (2012).
33. Perez, M. et al. Tau--an inhibitor of deacetylase HDAC6 function. Journal of Neurochemistry 109, 1756-1766 (2009).
34. Wloga, D. & Gaertig, J. Post-translational modifications of microtubules. J. Cell. Sci. 123, 3447-3455 (2010).
35. Leroy, K. et al. The function of the microtubule-associated protein tau is variably modulated by graded changes in glycogen synthase kinase-3beta activity. 465, 34-38 (2000).
36. Goode, B. L. et al. Functional interactions between the proline-rich and repeat regions of tau enhance microtubule binding and assembly. Mol. Biol. Cell 8, 353-365 (1997).
37. Gustke, N., Trinczek, B., Biernat, J., Mandelkow, E. M. & Mandelkow, E. Domains of tau protein and interactions with microtubules. Biochemistry 33, 9511-9522 (1994).
38. McDonald, L. & Beynon, R. J. Positional proteomics: preparation of aminoterminal peptides as a strategy for proteome simplification and characterization. Nat Protoc 1, 1790-1798 (2006).
39. Olsen, J. V., Ong, S.-E. & Mann, M. Trypsin cleaves exclusively C-terminal to arginine and lysine residues. Mol. Cell Proteomics 3, 608-614 (2004).
40. Chen, J., Kanai, Y., Cowan, N. J. & Hirokawa, N. Projection domains of MAP2 and tau determine spacings between microtubules in dendrites and axons. Nature 360, 674-677 (1992).
41. Dixit, R., Ross, J. L., Goldman, Y. E. & Holzbaur, E. L. F. Differential regulation of dynein and kinesin motor proteins by tau. Science 319, 1086-1089 (2008).
42. Magnani, E. et al. Interaction of tau protein with the dynactin complex. EMBO J 26, 4546-4554 (2007).
43. Hayashi, S. et al. Late-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation. Ann. Neurol. 51, 525-530 (2002).
44. Poorkaj, P. et al. An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype. Ann. Neurol. 52, 511-516 (2002).
45. Iyer, A. et al. A novel MAPT mutation, G55R, in a frontotemporal dementia patient leads to altered Tau function. PLoS ONE 8, e76409 (2013).
46. Fauquant, C. et al. Systematic identification of tubulin-interacting fragments of the microtubule-associated protein Tau leads to a highly efficient promoter of microtubule assembly. Journal of Biological Chemistry 286, 33358-33368 (2011).
47. Jeganathan, S., von Bergen, M., Brutlach, H., Steinhoff, H.-J. & Mandelkow, E. Global hairpin folding of tau in solution. Biochemistry 45, 2283-2293 (2006).
48. Carmel, G., Mager, E. M., Binder, L. I. & Kuret, J. The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. J Biol Chem 271, 32789-32795 (1996).
49. Spillantini, M. G. & Goedert, M. Tau pathology and neurodegeneration. The Lancet Neurology 12, 609-622 (2013).
50. Sudo, H. & Baas, P. W. Acetylation of microtubules influences their sensitivity to severing by katanin in neurons and fibroblasts. Journal of Neuroscience 30, 7215-7226 (2010).
51. Lacroix, B. et al. Tubulin polyglutamylation stimulates spastin-mediated microtubule severing. J. Cell Biol. 189, 945-954 (2010).
52. Zempel, H. et al. Amyloid-b oligomers induce synaptic damage via Taudependent microtubule severing by TTLL6 and spastin. EMBO J 32, 2920-2937 (2013).
53. Pianu, B., Lefort, R., Thuiliere, L., Tabourier, E. & Bartolini, F. Amyloid beta1-42 peptide regulates microtubule stability independently of tau. J. Cell. Sci. jcs.143750. doi:10.1242/jcs.143750 (2014).
54. Paholikova, K. et al. N-terminal Truncation of Microtubule Associated Protein Tau Dysregulates its Cellular Localization. J Alzheimers Dis. doi:10.3233/JAD- 140996 (2014).
55. Mailliot, C. et al. Pathological tau phenotypes. The weight of mutations, polymorphisms, and differential neuronal vulnerabilities. Ann. N. Y. Acad. Sci. 920, 107-114 (2000).
56. VizcaÕno, J. A. et al. The Proteomics Identifications database: 2010 update. Nucleic Acids Res. 38, D736-42 (2010).